Gastrointestinal effects of GLP-1 agonists
If cost is a factor, ubiquinone at a higher dose (600 mg/day) may offer comparable benefits to ubiquinol at a lower dose (200-400 mg/day)
There is no established dose equivalence table between these compounds because they have different receptor profiles and potencies
Additionally, gastrointestinal side effectsparticularly nausea and vomitingcan sometimes trigger autonomic responses, including perspiration
Change in vision (particularly in those with diabetic retinopathy) Hypoglycemia (low blood sugar) dizziness or light-headedness, sweating, shakiness, blurred vision, slurred speech, weakness, anxiety, hunger, headache, irritability or mood changes, confusion or drowsiness, fast heartbeat, or feeling jittery
In addition, levocarnitine buffers excess intramitochondrial acyl-CoA, regenerating free coenzyme A and potentially preventing inhibition of critical metabolic enzymes